Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Nivolumab|RADIATION: Radiation therapy|DRUG: Low dose doxorubicin|DRUG: Cyclophosphamide|DRUG: Cisplatin
Sponsor: The Netherlands Cancer Institute
Collaborators: Bristol-Myers Squibb